Skip to main content

 

OET SAMPLE LETTER - Robyn Harwood


                           WINNER ONLINE OET





I am writing to request a home visit for Ms. Harwood. She is diagnosed with right partial rotator cuff tear. She requires care and assistance from your facility.                                                    

                                                             Or                                                                                                                                                                                                                                                                 

I am writing to request home care and assistance for the above-mentioned patient. She is recovering from right partial rotator cuff tear and is being discharged today.

Ms.harwood presented to our hospital with pain and weakness in the right shoulder, especially when lifting the arm overhead. X-ray and MRI confirmed she has right partial rotator cuff tear. Therefore surgeon suggested surgery, but she prefers to try the nonsurgical treatment. Hence commenced with Ibuprofen ( dosage), cortisone (Dose), and daily physiotherapy. 



Ms.Harwood is a known case of type 2 diabetic Mellitus and is on regular medication metformin 500 mg morning. Its worth to mention, she is a widow, lives alone, and has no children. 


After discharge, It is important to monitor her blood glucose level every 4 hour as it can be elevated due to the side effects of the cortisone injection. It would be beneficial for Ms. Harwood if you can assist her in activities of daily living such as shower and house works/ house chores.May I remind you, her orthopedic review scheduled on 21/03/2011 ( It would be highly appreciated if you can help her to attend an orthopedic review scheduled on Date XXX )


Thank you for agreeing to take Ms. Harwood into your care  . please do not hesitate to contact me if you require further information Regarding Ms.Harwood


 I am Sibi from WINNER ONLINE OET.  OET Personal Training Programs starts at INR 3000 for One month — $ 85 or INR 6000 for four modules.  Time is flexible. We will teach you how to write & organize each letter. We are very experienced in OET & IELTS Training.  So why you pay $300 or INR 15000 for useless training where you won't get Individual attention  ??  ASK YOURSELF  !!! Also, we do have a refund policy, You can ask full money back within five classes if you are not satisfied. (After that, we won't process the refund). Still, its sounds great, No other trainers offer this, because here at winner we know what we are doing !!! Exactly So why you wait,Call us or whats app at + 91 6238 553 560 Email-support@winneronlineoet.com



Labels:
Location: Toronto, ON M5A 3W7, Canada

Comments

Post a Comment

Popular posts from this blog

Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma

Abstract BACKGROUND Nivolumab plus ipilimumab or nivolumab alone resulted in longer progression-free and overall survival than ipilimumab alone in a trial involving patients with advanced melanoma. We now report 5-year outcomes in the trial . METHODS We randomly assigned patients with previously untreated advanced melanoma to receive one of the following regimens: nivolumab (at a dose of 1 mg per kilogram of body weight) plus ipilimumab (3 mg per kilogram) every 3 weeks for four doses, followed by nivolumab (3 mg per kilogram every 2 weeks); nivolumab (3 mg per kilogram every 2 weeks) plus ipilimumab-matched placebo; or ipilimumab (3 mg per kilogram every 3 weeks for four doses) plus nivolumab-matched placebo. The two primary end points were progression-free survival and overall survival in the nivolumab-plus-ipilimumab group and in the nivolumab group, as compared with the ipilimumab group. RESULTS At a minimum follow-up of 60 months, the median overall survival was more...
Post a Comment
Read more

Lipid Management for the Prevention of Atherosclerotic Cardiovascular Disease

66  References Figure 1. Lipid Metabolism and Targets for Pharmacotherapy. In 1961, the investigators involved in the Framingham Heart Study identified serum cholesterol as one of the “factors of risk” for coronary heart disease. 1  Since then, numerous epidemiologic studies and randomized clinical trials have established that an elevated level of low-density lipoprotein (LDL) cholesterol is a major contributor to atherosclerotic cardiovascular disease. 2,3  As a consequence, the management of serum cholesterol levels has become a central objective in the effort to prevent cardiovascular events. The currently used therapies with demonstrated efficacy (see Table S1 in the  Supplementary Appendix , available with the full text of this article at NEJM.org) predominantly target the apolipoprotein B–associated lipoproteins reflected in levels of LDL cholesterol, non–high-density lipoprotein cholesterol (non-HDL cholesterol), and triglycerides ( Figure 1 ). Figur...
Post a Comment
Read more